OLBA HEALTHCARE HOLDINGS, Inc. (TYO:2689)
2,054.00
-4.00 (-0.19%)
Jun 4, 2026, 3:30 PM JST
OLBA HEALTHCARE HOLDINGS Revenue
OLBA HEALTHCARE HOLDINGS had revenue of 33.33B JPY in the quarter ending March 31, 2026, with 4.65% growth. This brings the company's revenue in the last twelve months to 126.00B, up 3.58% year-over-year. In the fiscal year ending June 30, 2025, OLBA HEALTHCARE HOLDINGS had annual revenue of 122.70B with 3.49% growth.
Revenue (ttm)
126.00B
Revenue Growth
+3.58%
P/S Ratio
0.10
Revenue / Employee
90.45M
Employees
1,393
Market Cap
12.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 122.70B | 4.14B | 3.49% |
| Jun 30, 2024 | 118.56B | 8.09B | 7.32% |
| Jun 30, 2023 | 110.47B | 2.51B | 2.33% |
| Jun 30, 2022 | 107.96B | -5.02B | -4.44% |
| Jun 30, 2021 | 112.98B | 5.08B | 4.71% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| Satudora Holdings | 100.36B |
| Daiken Medical | 10.29B |
| Taiko Pharmaceutical | 6.16B |
| RaQualia Pharma | 3.81B |